Onegene Biotechnology
PrivateLast Round
Series B
May 1, 2022
Total Funding Raised
$48.08M
Company Overview
Onegene Biotechnology operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series B round in May 2022.
Onegene Biotechnology is a biotechnology company that develops multi-target therapeutic drugs for the treatment of cancer, metabolic, and inflammatory diseases using its proprietary protein conjugation platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onegene Biotechnology Comparables
Compare Onegene Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VALANX Biotech | 79% | |
| ProAbTech Co., Ltd. | 79% | |
| ABL Bio, Inc. | 75% |
For institutional investors. Book with your work email.
Onegene Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 1, 2022 | ||||
| Series A | Feb 18, 2021 | ||||
| Pre Seed | Aug 1, 2020 | ||||
| Accelerator | Sep 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Onegene Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series A, Series B |
| Shinhan Venture Investment | Series B |
| Bluepoint Partners | Accelerator |
| UTC Investment | Series A, Series B |
| Premier Partners | Series A, Series B |
| Timefolio Asset Management | Series B |
| Korea Investment & Securities Co., Ltd. | Series B |
For institutional investors. Book with your work email.
Onegene Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Onegene Biotechnology's valuation, stock price, and market status.
Is Onegene Biotechnology a public or private company?
Onegene Biotechnology is a private company.
What is the current stock price of Onegene Biotechnology?
Onegene Biotechnology is a private company, so its shares have no public market price. Caplight tracks Onegene Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Onegene Biotechnology worth (valuation)?
Valuation information for Onegene Biotechnology is not publicly available.
Can I buy Onegene Biotechnology stock?
Onegene Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Onegene Biotechnology's last funding round?
Onegene Biotechnology's most recent funding round was Series B on May 1, 2022.
Who are the main investors in Onegene Biotechnology?
Key investors in Onegene Biotechnology include BNH INVESTMENT, Shinhan Venture Investment, Bluepoint Partners, UTC Investment, Premier Partners.
Will Onegene Biotechnology IPO soon?
No public IPO plans have been announced for Onegene Biotechnology.
How can I track Onegene Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Onegene Biotechnology's shares on secondary markets.